These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9639553)

  • 41. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
    Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
    De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
    Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for an inhibitory effect of physiological levels of insulin on the growth hormone (GH) response to GH-releasing hormone in healthy subjects.
    Lanzi R; Manzoni MF; Andreotti AC; Malighetti ME; Bianchi E; Sereni LP; Caumo A; Luzi L; Pontiroli AE
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2239-43. PubMed ID: 9215300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.
    Bramnert M; Segerlantz M; Laurila E; Daugaard JR; Manhem P; Groop L
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1455-63. PubMed ID: 12679422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
    Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute growth hormone administration causes exaggerated increases in plasma lactate and glycerol during moderate to high intensity bicycling in trained young men.
    Lange KH; Larsson B; Flyvbjerg A; Dall R; Bennekou M; Rasmussen MH; Ørskov H; Kjaer M
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4966-75. PubMed ID: 12414860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth hormone, insulin, and insulin-like growth factor-1 in hypermobility syndrome.
    Denko CW; Boja B
    J Rheumatol; 2001 Jul; 28(7):1666-9. PubMed ID: 11469476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IGF-I levels rise and GH responses to GHRH decrease during long-term prednisone treatment in man.
    Borges MH; Pinto AC; DiNinno FB; Camacho-Hübner C; Grossman A; Kater CE; Lengyel AM
    J Endocrinol Invest; 1999 Jan; 22(1):12-7. PubMed ID: 10090131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth hormone response to clonidine in anovulatory infertile women resistant to clomiphene citrate stimulation.
    Rossato P; Minuto F; Garrone S; Ragni N
    Fertil Steril; 2000 Jan; 73(1):78-84. PubMed ID: 10632417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Growth hormone-induced insulin resistance in human subjects involves reduced pyruvate dehydrogenase activity.
    Nellemann B; Vendelbo MH; Nielsen TS; Bak AM; Høgild M; Pedersen SB; Biensø RS; Pilegaard H; Møller N; Jessen N; Jørgensen JO
    Acta Physiol (Oxf); 2014 Feb; 210(2):392-402. PubMed ID: 24148194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between cognitive function, growth hormone and insulin-like growth factor I plasma levels in aged subjects.
    Rollero A; Murialdo G; Fonzi S; Garrone S; Gianelli MV; Gazzerro E; Barreca A; Polleri A
    Neuropsychobiology; 1998; 38(2):73-9. PubMed ID: 9732206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of ovary suppression by a long-acting GnRH-agonist on circulating GH, insulin-like growth factor I and insulin levels in women with polycystic ovary syndrome.
    Tropeano G; Liberale I; Vuolo IP; Barini A; Caroli G; Carfagna P; Menini E
    J Endocrinol Invest; 1997 Apr; 20(4):220-4. PubMed ID: 9211130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of fasting on growth hormone signaling and action in muscle and fat.
    Moller L; Dalman L; Norrelund H; Billestrup N; Frystyk J; Moller N; Jorgensen JO
    J Clin Endocrinol Metab; 2009 Mar; 94(3):965-72. PubMed ID: 19066303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults.
    Laursen T; Gravholt CH; Heickendorff L; Drustrup J; Kappelgaard AM; Jørgensen JO; Christiansen JS
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1222-8. PubMed ID: 11238512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin and GH secretion in adolescent girls with irregular cycles: polycystic vs multifollicular ovaries.
    Villa P; Rossodivita A; Fulghesu AM; Cucinelli F; Barini A; Apa R; Belosi C; Lanzone A
    J Endocrinol Invest; 2003 Apr; 26(4):305-11. PubMed ID: 12841537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum insulin but not leptin is associated with spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in normal volunteers with and without weight loss.
    Manglik S; Cobanov B; Flores G; Nadjafi R; Tayek JA
    Metabolism; 1998 Sep; 47(9):1127-33. PubMed ID: 9751243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men.
    Veldhuis JD; Bidlingmaier M; Anderson SM; Wu Z; Strasburger CJ
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3304-10. PubMed ID: 11443205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The association of birthweight with maternal and cord serum and amniotic fluid growth hormone and insulin levels, and with neonatal and maternal factors in pregnant women who delivered at term.
    Osmanağaoğlu MA; Osmanağaoğlu S; Bozkaya H
    J Perinat Med; 2005; 33(2):149-55. PubMed ID: 15843266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Establishment of reference values for endocrine tests. Part VII: growth hormone deficiency.
    Eskes SA; Tomasoa NB; Endert E; Geskus RB; Fliers E; Wiersinga WM
    Neth J Med; 2009 Apr; 67(4):127-33. PubMed ID: 19581656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.